BLUELIGHT THERAPEUTICS
DEAD

Serial Number

88872100

Owner

BLUELIGHT THERAPEUTICS, INC.

Attorney

Brandon P. Leahy

Filing Date

Apr 14, 2020

Add to watchlist:

No watchlists yet
View on USPTO

BLUELIGHT THERAPEUTICS Trademark

Serial Number: 88872100

BLUELIGHT THERAPEUTICS is a trademark filed by BLUELIGHT THERAPEUTICS, INC. on April 14, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

BLUELIGHT THERAPEUTICS, INC. (2 trademarks)

170 HARBOR WAY, SUITE 100
SOUTH SAN FRANCISCO, CA 94080

Entity Type: 03

Biodesy, Inc. (2 trademarks)

384 Oyster Point Blvd, #8
South San Francisco, CA 94080

Entity Type: 03

Trademark Details

Filing Date

April 14, 2020

Registration Date

Not Registered

Published for Opposition

June 1, 2021

Goods & Services

Scientific instruments, namely, optical measurement systems comprised of lasers not for medical use, prisms, light detectors and downloadable and recorded computer software and hardware; liquid handling systems comprised of pipettors; aspirators not being medical devices; laboratory liquid dispensers; computer hardware for use in researching and analyzing proteins and other biomolecules; biosensors not for detecting infectious diseases, namely, biosensors for detecting structural changes in biomolecules; laboratory equipment, namely, plates, slides, and flow cells having multi-well arrays for use in chemical analysis, biological analysis, and/or patterning for scientific, laboratory, and medical research; computer hardware for use in laboratory research and medical research; downloadable computer software for use in researching and analyzing proteins and other biomolecules

Pharmaceutical and medical therapeutic preparations for the treatment of oncology, immunology, metabolic disorders, neurology, rare genetic disorders, psychiatric disorders, gastroenterology, renal disease, cardiovascular disease, dermatology, respiratory disease, bone disease, sexual dysfunction, ocular disease, hearing disorders and other related diseases and disorders; Pharmaceutical and medical preparations for the treatment of oncology, immunology, metabolic disorders, neurology, rare genetic disorders, psychiatric disorders, gastroenterology, renal disease, cardiovascular disease, dermatology, respiratory disease, bone disease, sexual dysfunction, ocular disease, hearing disorders and other related diseases and disorders

Biochemical reagents used for non-medical purposes; non-medical biochemical reagents and consumables, namely, preparation reagents, labeling reagents, immobilizing reagents, detection reagents and buffers for scientific, research or diagnostic use used for non-medical purposes; biochemical reagents and consumables, namely, preparation reagents, labeling reagents, immobilization reagents, detection reagents and buffers used in analyzing proteins and other biomolecules used for non-medical purposes; chemical test kits for use in analyzing proteins and other biomolecules for non-medical purposes

Laboratory research services relating to analysis of proteins and biomolecules; medical laboratory services related to analysis of proteins and biomolecules; providing an online searchable database in the field of protein and biomolecule analysis; providing temporary use of on-line non-downloadable computer software for use in researching and analyzing proteins and other biomolecules; pharmaceutical research services for others; Biochemical research and development services in the field of conformational perturbation; Research and development of pharmaceuticals; Research and development of technology in the field of pharmaceuticals; Development of pharmaceutical preparations and medicines; Drug development and discovery; Research and development of therapeutic drugs for the prevention or treatment of human diseases; Scientific research in the field of drug discovery and development for others; Biomedical research services; Scientific research; Preclinical development of therapeutic products

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Feb 28, 2022 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 28, 2022 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 27, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 1, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jun 1, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 12, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 27, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 19, 2021 XAEC
ASSIGNED TO LIE
Apr 19, 2021 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 19, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 19, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 19, 2021 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 18, 2021 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Nov 17, 2020 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 4, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 5, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 5, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 5, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 30, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jun 30, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jun 30, 2020 CNRT
ASSIGNED TO EXAMINER
Jun 30, 2020 DOCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 27, 2020 ASGN
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 22, 2020 NWOS
NEW APPLICATION ENTERED
Apr 17, 2020 NWAP